Select a community to browse its collections.

Akershus Universitetssykehus HF [153]
Arbeidsforskningsinstituttet (AFI) [443]
By- og regionforskningsinstituttet (NIBR) [1641]
Fakultet for helsevitenskap (HV) [4179]
Fakultet for lærerutdanning og internasjonale studier (LUI) [2379]
Fakultet for samfunnsvitenskap (SAM) [3286]
Fakultet for teknologi, kunst og design (TKD) [2693]
Forbruksforskningsinstituttet (SIFO) [576]
Seniorsenteret [39]
Senter for profesjonsforskning (SPS) [466]
Senter for velferds- og arbeidslivsforskning (SVA) [1119]
Sentraladministrasjonen [3435]
Velferdsforskningsinstituttet (NOVA) [655]
  • Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC-MS and anti-Xa assay? 

    Røed-Undlien, Henriette; Schultz, Nina Haagenrud; Amundsen, Erik Koldberg; Wollmann, Birgit Malene Tovik; Molden, Espen; Akerkar, Rupali Rajendra; BJØRNSTAD, JOHANNES (Peer reviewed; Journal article, 2024)
    Introduction: Hemolytic interference may impact various laboratory tests, including coagulation analyses. Apixaban is the most commonly used direct oral anticoagulant in Norway, and there is lacking knowledge on how ...
  • Curriculum agility principles for transformative innovation in engineering education 

    Brink, Suzanne; De Hei, Miranda; Sjoer, Ellen; Carlsson, Carl Johan; Georgsson, Fredrik; Keller, Elizabeth D.; McCartan, Charles; Enelund, Mikael; Lyng, Reidar; Admiraal, Wilfried (Peer reviewed; Journal article, 2024)
    Transformative curriculum innovation is needed in engineering education programmes, to continuously keep up to date with developments in the professional and research disciplines, in society, technology and pedagogy, ...
  • Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 

    Naghavi, Mohsen; Ong, Kanyin Liane; Aali, Amirali; S Ababneh, Hazim S Ababneh; Abate, Yohannes Habtegiorgis; Abbafati, Cristiana ; Abbasgholizadeh, Rouzbeh; Abbasian, Mohammadreza; Abbasi-Kangevari, Mohsen; Hedayat, Abbastabar; Abd ElHafeez, Samar; Abdelmasseh, Michael; Abd-Elsalam, Sherief; Abdelwahab, Ahmed Abdelwahab; Mohammad, Abdollahi; Abdollahifar, Mohammad-Amin; Abdoun, Meriem; Abdulah, Deldar Morad ; Abdullahi, Auwal; Abebe, Mesfin; Shawel Abebe, Samrawit; Aidin, Abedi; Kedir Hussein, Abegaz; Abhilash, E S ; Abidi, Hassan ; Abiodun, Olumide; Aboagye, Richard Gyan; Hassan, Abolhassani; Abolmaali, Meysam; Abouzid, Mohamed; Bjørge, Tone; Hailu, Alemayehu; Sagoe, Dominic; Wojewodzic, Marcin Wlodzimierz; Nauman, Javaid; Knudsen, Ann Kristin Skrindo; Madsen, Christian; Forthun, Ingeborg; Kisa, Adnan; Kisa, Sezer; Wolf, Axel; Eikemo, Terje Andreas; Vollset, Stein Emil; Zou, Zhiyong; Zuhlke, Liesl Joanna; Zumla, Alimuddin; Zweck, Elric; Zyoud, Samer H.; Wool, Eve E; Murray, Christopher J.L. (Peer reviewed; Journal article, 2024)
    Background Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy ...
  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 

    Ferrari, Alize J; Santomauro, Damian Francesco; Aali, Amirali ; Abate, Yohannes Habtegiorgis; Abbafati, Cristiana; Abbastabar, Hedayat; ElHafeez, Samar Abd; Abdelmasseh, Michael ; Abd-Elsalam, Sherief ; Abdollahi, Arash; Abdullahi, Auwal; Kedir Hussein, Abegaz; Abeldaño Zuñiga, Roberto Ariel; Aboagye, Richard Gyan; Hassan, Abolhassani; Abreu, Lucas Guimarães; Abualruz, Hasan; Abu-Gharbieh, Eman; Abu-Rmeileh, Niveen ME; Ackerman, Ilana N; Addo, Isaac Yeboah; Addolorato, Giovanni; Adebiyi, Akindele Olupelumi; Adepoju, Abiola Victor; Omoponle Adewuyi, Habeeb; Afyouni, Shadi; Afzal, Saira ; Afzal, Sina; Agodi, Antonella ; Ahmad, Aqeel; Ahmad, Danish; Bjørge, Tone; Sagoe, Dominic; Eikemo, Terje Andreas; Steiner, Timothy J.; Kisa, Adnan; Kisa, Sezer; Wolf, Axel; Knudsen, Ann Kristin Skrindo; Vollset, Stein Emil; Zhou, Juexiao; Zhu, Zhaohua; Ziafati, Makan; Zielińska, Magdalena; Zimsen, Stephanie R M; Zoladl, Mohammad; Zumla, Alimuddin; Zyoud, Samer H.; Theo, Vos; Murray, Christopher JL (Peer reviewed; Journal article, 2024)
    Background Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury ...
  • Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: A randomized phase 2b trial 

    Andresen, Nikolai Kragøe; Røssevold, Andreas Hagen; Quaghebeur, Claire; Gilje, Bjørnar; Boge, Beate; Gombos, Andrea; Falk, Ragnhild Sørum; Ruud, Randi Margit; Julsrud, Lars; Garred, Øystein; Russnes, Hege Elisabeth Giercksky; Lereim, Ragnhild Reehorst; Chauhan, Sudhir Kumar; Lingjærde, Ole Christian; Dunn, Claire; Naume, Bjørn; Kyte, Jon A (Peer reviewed; Journal article, 2024)
    Background Immune checkpoint inhibitors have shown minimal clinical activity in hormone receptor-positive metastatic breast cancer (HR+ mBC). Doxorubicin and low- dose cyclophosphamide are reported to induce immune ...

View more